Cymat Technologies Updates on Private Placement Financing
Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) has recently provided significant insights regarding their ongoing non-brokered private placement of equity Units. This private placement plan promises to release approximately 11,934,615 equity Units generating gross proceeds of around $1,551,500.
Details of the Offering and Units
Each Unit is set to be priced at $0.13 and includes one Common Share along with one Common Share Purchase Warrant. Notably, the Warrants will allow the holder to purchase another Common Share at $0.18 for a period spanning twenty-four months. A critical condition associated with the Warrants is that Warrant Holders are precluded from exercising a number that would trigger the creation of a new Insider without proper submissions to the TSX Venture Exchange.
Insider Participation and Conditions
It is important to highlight that no insiders of Cymat Technologies will be involved in this offering. Should exercising the Warrants lead to the formation of a new Insider, Cymat will utilize an exemption from the standard valuation requirements stipulated under MI 61-101. This exemption is based on the premise that any Insider Participation will not exceed 25% of the total market capitalization of the Company.
Future Plans and Use of Proceeds
The proceeds from this Offering are intended for enhancing capital equipment purchases that are crucial for an extensive business development strategy, alongside funding necessary working capital requirements. This financial bolstering is expected to support Cymat's operational efficiency and growth objectives.
Compliance with Securities Regulations
According to Canadian securities laws, any securities issued under this offering will be subject to a trading hold period lasting four months from their issue date. These conditions affirm that Cymat is committed to adhering to regulatory requirements and maintaining transparency with their investors.
About Cymat Technologies Ltd.
Cymat Technologies Ltd. holds global rights, through established patents and expertise, to develop and sell Stabilized Aluminum Foam (SAF). This innovative material is ultra-lightweight and metallic, generated by injecting gases into a molten aluminum alloy infused with ceramic particles. The resulting SAF is an advanced, recyclable material ideal for various applications, including architectural design, military, and automotive sectors. Cymat's architectural SAF is marketed under the Alusion™ brand while its automotive and military offerings are branded as SmartMetal™.
For more details about Cymat Technologies and their products, please visit their official website.
Frequently Asked Questions
What is Cymat Technologies known for?
Cymat Technologies is primarily recognized for their innovative Stabilized Aluminum Foam (SAF), which is used across multiple industries for its lightweight and resilient properties.
What is the goal of the current equity offering?
The primary goal of the current equity offering is to secure funds for capital equipment purchases as part of a broader strategic business development initiative.
How many equity units are being issued in the offering?
In this private placement, Cymat Technologies intends to issue approximately 11,934,615 equity units.
Will company insiders be participating in the offering?
No, Cymat Technologies has confirmed that no insiders will participate in this offering.
What is the pricing of each equity unit?
Each equity unit is being offered at a price of $0.13, which includes a Common Share and a Common Share Purchase Warrant.
